Global Ranitidine Market (2026-2031) - Rising Prevalence of Gastroesophageal Reflux Disease and Peptic Ulcers Drives Growth

Rising GERD and ulcer cases support low-cost generic demand in price-sensitive markets. Reformulated tablets, liquids and hospital injections offer opportunities despite safety concerns.Dublin, Aug.
Conventus Law

India – Enforcement Vs. Due Process: Lessons From The FDA–Cadila Matter On Drug Regulation In Maharashtra.

Lessons From The FDA–Cadila Matter On Drug Regulation In Maharashtra. Legal News and Analysis - India - Dispute Resolution, ...
Medscape

Ranitidine Is Back After Five Years. Here's What Changed — and What Didn't — for H2 Blockers

Five years after an NDMA-driven withdrawal, ranitidine has FDA approval again. A practical guide to all four H2 blockers, and where each still fits.